5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Gianni, Luca, Prof, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Starosławska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia Valeria, MD, Magazzù, Domenico, PhD, McNally, Virginia, PhD, Douthwaite, Hannah, MSc, Ross, Graham, FFPM, Valagussa, Pinuccia, BS
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article
Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy
Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Ruiz, Antonio Carlos Sánchez, Láng, István, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, Jennifer, Muñoz, Montserrat
Published in Journal of clinical oncology (10.09.2017)
Published in Journal of clinical oncology (10.09.2017)
Get full text
Journal Article
Final overall survival (OS) analysis of PHEREXA: A randomized phase III trial of trastuzumab (H) + capecitabine (X) ± pertuzumab (P) in patients with HER2-positive metastatic breast cancer (MBC) who experienced disease progression during or after H-based therapy
Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Sánchez Ruiz, Antonio Carlos, Lang, Istvan, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, Jennifer, Munoz, Montserrat
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Abstract OT3-1-01: A two-cohort, phase II, cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory, or early breast cancer
Swain, Sandra M, Ewer, Michael S, Douthwaite, Hannah, Szado, Tania, Waldron-Lynch, Maeve, Dang, Chau
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Efficacy of trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (MBC) previously treated with pertuzumab (P)
Urruticoechea, Ander, Im, Seock-Ah, Munoz, Montserrat, Baselga, Jose, Yardley, Denise A., Heeson, Sarah, Jones, Sarah, Knott, Adam, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Swain, Sandra M.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
PHEREXA: A phase III study of trastuzumab (H) + capecitabine (X) ± pertuzumab (P) for patients (pts) who progressed during/after one line of H-based therapy in the HER2-positive metastatic breast cancer (MBC) setting
Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Sánchez-Ruiz, Antonio Carlos, Lang, Istvan, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, Jennifer, Munoz, Montserrat
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
HER2-양성 유방암의 치료
BRADLEY DENISE, WALDRON LYNCH MAEVE, DOUTHWAITE HANNAH, ENG WONG JENNIFER
Year of Publication 28.06.2019
Get full text
Year of Publication 28.06.2019
Patent
Five-year analysis of the phase II NeoSphere trial evaluating four cycles of neoadjuvant docetaxel (D) and/or trastuzumab (T) and/or pertuzumab (P)
Gianni, Luca, Pienkowski, Tadeusz, Im, Young-Hyuck, Tseng, Ling-Ming, Liu, Mei-Ching, Lluch, Ana, Staroslawska, Elzbieta, de la Haba-Rodriguez, Juan, Im, Seock-Ah, Pedrini, Jose Luiz, Poirier, Brigitte, Morandi, Paolo, Semiglazov, Vladimir, Srimuninnimit, Vichien, Bianchi, Giulia Valeria, McNally, Virginia, Douthwaite, Hannah, Ross, Graham, Valagussa, Pinuccia
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
TREATMENT OF HER2-POSITIVE BREAST CANCER
BRADLEY, Denise, DOUTHWAITE, Hannah, WALDRON-LYNCH, Maeve, ENG-WONG, Jennifer
Year of Publication 11.09.2019
Get full text
Year of Publication 11.09.2019
Patent
Treatment of HER2-positive breast cancer
Waldron-Lynch, Maeve, Bradley, Denise, Eng-Wong, Jennifer, Douthwaite, Hannah
Year of Publication 16.05.2019
Get full text
Year of Publication 16.05.2019
Patent
TREATMENT OF HER2-POSITIVE BREAST CANCER
BRADLEY, Denise, DOUTHWAITE, Hannah, WALDRON-LYNCH, Maeve, ENG-WONG, Jennifer
Year of Publication 31.05.2018
Get full text
Year of Publication 31.05.2018
Patent
TREATMENT OF HER2-POSITIVE BREAST CANCER
Waldron-Lynch, Maeve, Bradley, Denise, Eng-Wong, Jennifer, Douthwaite, Hannah
Year of Publication 17.05.2018
Get full text
Year of Publication 17.05.2018
Patent
TREATMENT OF HER2-POSITIVE BREAST CANCER
BRADLEY, Denise, DOUTHWAITE, Hannah, WALDRON-LYNCH, Maeve, ENG-WONG, Jennifer
Year of Publication 11.05.2018
Get full text
Year of Publication 11.05.2018
Patent
TREATMENT OF HER2-POSITIVE BREAST CANCER
WALDRON-LYNCH, MAEVE, DOUTHWAITE, HANNAH, ENG-WONG, JENNIFER, BRADLEY, DENISE
Year of Publication 11.05.2018
Get full text
Year of Publication 11.05.2018
Patent
TREATMENT OF HER2-POSITIVE BREAST CANCER
BRADLEY DENISE, DOUTHWAITE HANNAH, ENG-WONG JENNIFER, WALDRON-LYNCH MAEVE
Year of Publication 26.11.2019
Get full text
Year of Publication 26.11.2019
Patent
TREATMENT OF HER2-POSITIVE BREAST CANCER
Jennifer ENG-WONG, Denise BRADLEY, Maeve WALDRON-LYNCH, Hannah DOUTHWAITE
Year of Publication 14.10.2019
Get full text
Year of Publication 14.10.2019
Patent
Treatment of HER2-positive breast cancer
WALDRON-LYNCH, MAEVE, DOUTHWAITE, HANNAH, ENG-WONG, JENNIFER, BRADLEY, DENISE
Year of Publication 01.06.2018
Get full text
Year of Publication 01.06.2018
Patent